Related Experiment Video
Updated: Aug 15, 2026

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
Published on: August 28, 2015
Characterization of the selectivity of a phenytoin imprinted polymer
1Research Group of Technical Analytical Chemistry, Hungarian Academy of Sciences, Budapest University of Technology and Economics, Szt. Gellért tér 4, H-1111 Budapest, Hungary. pap-t@mail.bme.hu
Abstract:
The selectivity of analytical methods based on molecularly imprinted polymers (MIPs) is due to the preferential adsorption of the analyte(s) as compared to other substances (interferences). This paper shows the theoretical and practical difficulties, which have to be considered and solved when real samples need to be analysed in a wide range of analyte and interferant concentrations. It is shown that the estimation of interference effects requires either many measurements or a realistic model of the adsorption equilibrium in mixed solutions of the analyte and the interferences. Examples are shown for positive (cooperative) interference effects, for better experimental design and interpretation of binary isotherm measurements and for establishing the chemical model of interference from selectivity measurements. The usual MIP model consisting of a cavity, which closely fits the shape of the template from all sides, appears unsuitable for this MIP, and it is replaced with a more realistic, more open model. The applicability of the results to using non-imprinted polymers as selective sorbents and to screening drug candidates is also shown.
More Related Videos
10:10Transport Properties of Ibuprofen Encapsulated in Cyclodextrin Nanosponge Hydrogels: A Proton HR-MAS NMR Spectroscopy Study
Published on: August 15, 2016
09:33Phthalic Acid Ester-Binding DNA Aptamer Selection, Characterization, and Application to an Electrochemical Aptasensor
Published on: March 21, 2018
Related Concept Videos
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Modified-Release Drug Delivery Systems: Rate-Programmed II
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Site-Targeted Drug Delivery Systems: Polymeric Carriers